Development of A10P3C, an isoform-selective inhibitor of EGLN2, for targeting breast cancer. (pnas.org)

Authors: Liang Q … Zhang Q Journal: PNAS Published: 2026-10-01 DOI: https://doi.org/10.1073/pnas.2613915123